Epstein-Barr Virus–Associated Posttransplantation Lymphoproliferative Disorder after High-Dose Immunosuppressive Therapy and Autologous CD34-Selected Hematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases

High-dose immunosuppressive therapy followed by autologous hematopoietic stem cell transplantation (HSCT) is currently being evaluated for the control of severe autoimmune diseases. The addition of antithymocyte globulin (ATG) to high-dose chemoradiotherapy in the high-dose immunosuppressive therapy...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Nash, Richard A., Dansey, Roger, Storek, Jan, Georges, George E., Bowen, James D., Holmberg, Leona A., Kraft, George H., Mayes, Maureen D., McDonagh, Kevin T., Chen, Chien-Shing, DiPersio, John, LeMaistre, C. Fred, Pavletic, Steven, Sullivan, Keith M., Sunderhaus, Julie, Furst, Daniel E., McSweeney, Peter A.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2003
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2956744/
https://ncbi.nlm.nih.gov/pubmed/14506660
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة